Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This bill amends the Federal Food, Drug, and Cosmetic Act to expand the Secretary of Health and Human Services’ authority to destroy imported articles (now defined as “drug, device, or other article”) that the Secretary determines present a "significant public health concern," including articles refused admission. It makes it a prohibited act to move, introduce, or deliver for introduction into interstate commerce (including export) any article the Secretary has decided to destroy under that authority.
Scope and definition: disagreement over how broadly “significant public health concern” should be interpreted.
Relative to its intended legislative type, this bill cleanly amends specific FD&C Act provisions to expand destruction authority and create a related prohibited act, giving clear textual changes and a short regulatory timeline.
This bill amends the Federal Food, Drug, and Cosmetic Act to expand the Secretary of Health and Human Services’ authority to destroy imported articles (now defined as “drug, device, or other article”) that the Secretary determines present a "significant public health concern," including articles refused admission.
It makes it a prohibited act to move, introduce, or deliver for introduction into interstate commerce (including export) any article the Secretary has decided to destroy under that authority.
The amendments take effect 180 days after enactment, and the Secretary (through the FDA Commissioner) must finalize necessary regulatory revisions within 90 days and ensure consistency with applicable international agreements.
On substance the bill is a modest, administratively focused expansion of existing FDA enforcement authority with limited fiscal impact, which increases its chances compared with sweeping or highly partisan measures. However, the potential for trade and export-related controversy, absence of explicit implementation funding or stakeholder accommodations, and any pushback from affected commercial actors reduce its certainty. Success will depend on committee handling, stakeholder responses, and whether it is advanced as a standalone bill or folded into broader legislation.
Relative to its intended legislative type, this bill cleanly amends specific FD&C Act provisions to expand destruction authority and create a related prohibited act, giving clear textual changes and a short regulatory timeline. However, it leaves several operationally important details unspecified.
Scope and definition: disagreement over how broadly “significant public health concern” should be interpreted.
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope and definition: disagreement over how broadly “significant public health concern” should be interpreted.
A mainstream progressive would likely view the bill positively as a concrete public-health protection that gives the federal government an explicit tool to prevent hazardous imports (contaminated food, counterfeit or unsafe drugs/devices) from entering U.S. markets or being redistributed.
They would appreciate the emphasis on preventing public exposure to dangerous goods but would be concerned about implementation details such as transparency, environmental and worker-safety standards for destruction, and procedural protections for affected parties.
Overall, they would see the bill as aligned with public-health and consumer-protection priorities, provided safeguards are added.
A pragmatic centrist would generally favor stronger tools to prevent hazardous imports from harming consumers, but would be attentive to rules, costs, and legal risks.
They would view the policy as reasonable in principle but would want precise definitions, clear procedures, interagency coordination (Customs, USDA, etc.), and assurances that the approach complies with international obligations and minimizes unintended trade disruption.
Their support would be conditional on sensible, implementable regulations and safeguards.
A mainstream conservative would be skeptical of expanding federal seizure and destruction authority without strong safeguards for property rights and due process.
While they may accept narrow destruction authority for clear and imminent public-health threats, they would be concerned that the bill’s language is broad, could impose regulatory costs on trade and logistics, and represents additional federal power over private property and commerce.
Their view would be cautious to opposed unless the scope is limited and procedural protections and compensation rules are added.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On substance the bill is a modest, administratively focused expansion of existing FDA enforcement authority with limited fiscal impact, which increases its chances compared with sweeping or highly partisan measures. However, the potential for trade and export-related controversy, absence of explicit implementation funding or stakeholder accommodations, and any pushback from affected commercial actors reduce its certainty. Success will depend on committee handling, stakeholder responses, and whether it is advanced as a standalone bill or folded into broader legislation.
The bill has not accumulated any surfaced votes yet.
Scope and definition: disagreement over how broadly “significant public health concern” should be interpreted.
On substance the bill is a modest, administratively focused expansion of existing FDA enforcement authority with limited fiscal impact, whi…
Relative to its intended legislative type, this bill cleanly amends specific FD&C Act provisions to expand destruction authority and create a related prohibited act, giving clear textual changes and a short regulatory t…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.